LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 156 filers reported holding LEGEND BIOTECH CORP in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $296,153 | -13.9% | 4,409 | -11.5% | 0.18% | -11.8% |
| Q2 2023 | $343,907 | +20.1% | 4,982 | -16.1% | 0.20% | +29.1% |
| Q1 2023 | $286,330 | -1.6% | 5,938 | +1.8% | 0.16% | +3.9% |
| Q4 2022 | $291,133 | +33.5% | 5,832 | +9.0% | 0.15% | +74.7% |
| Q3 2022 | $218,000 | -24.8% | 5,351 | +1.5% | 0.09% | -18.7% |
| Q2 2022 | $290,000 | +150.0% | 5,274 | +65.1% | 0.11% | +105.8% |
| Q1 2022 | $116,000 | -26.6% | 3,195 | -5.6% | 0.05% | -13.3% |
| Q4 2021 | $158,000 | -40.6% | 3,384 | -35.7% | 0.06% | -48.7% |
| Q3 2021 | $266,000 | +17.2% | 5,265 | -4.8% | 0.12% | +25.8% |
| Q2 2021 | $227,000 | -22.0% | 5,531 | -44.8% | 0.09% | -24.4% |
| Q1 2021 | $291,000 | +5.1% | 10,016 | +1.9% | 0.12% | +7.0% |
| Q4 2020 | $277,000 | – | 9,834 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |